|
RAB28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56370000281569E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.98430000208916E-08 |
| Normal-vs-Stage2 |
5.390600E-04 |
| Normal-vs-Stage3 |
6.20770002068838E-09 |
| Normal-vs-Stage4 |
1.129650E-01 |
| Stage1-vs-Stage2 |
5.308800E-01 |
| Stage1-vs-Stage3 |
2.844200E-01 |
| Stage1-vs-Stage4 |
6.737900E-02 |
| Stage2-vs-Stage3 |
1.742960E-01 |
| Stage2-vs-Stage4 |
3.073200E-01 |
| Stage3-vs-Stage4 |
6.388100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02090000289701E-08 |
| Normal-vs-AfricanAmerican |
2.529600000023E-06 |
| Normal-vs-Asian |
1.323770E-02 |
| Caucasian-vs-AfricanAmerican |
7.446400E-01 |
| Caucasian-vs-Asian |
9.227800E-01 |
| AfricanAmerican-vs-Asian |
9.865400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.20189999356313E-09 |
| Normal-vs-Female |
4.92139999996866E-06 |
| Male-vs-Female |
1.714960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.88140999999309E-05 |
| Normal-vs-Extreme_Weight |
2.98169999801701E-08 |
| Normal-vs-Obese |
7.23939999947021E-07 |
| Normal-vs-Extreme_Obese |
4.164100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.629400E-01 |
| Normal_Weight-vs-Obese |
9.570400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.771400E-01 |
| Extreme_Weight-vs-Obese |
5.820800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.146800E-01 |
| Obese-vs-Extreme_Obese |
8.552200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.644800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.07620000022735E-07 |
| Normal-vs-Age(61-80Yrs) |
1.01809999986102E-07 |
| Normal-vs-Age(81-100Yrs) |
4.12400000004975E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.023200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.073400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.095000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.801800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.304000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.057600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.79120000054489E-07 |
| Normal-VS-Type2 PRCC |
8.22280021850474E-10 |
| Normal-VS-KIRP CIMP |
1.245960E-02 |
| Normal-VS-Unclassified PRCC |
9.85480000048611E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.499600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.230800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.795200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.576810E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.612800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.580800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.02105040772949E-13 |
| Normal-vs-N1 |
1.196350E-01 |
| Normal-vs-N2 |
1.543720E-02 |
| N0-vs-N1 |
9.391900E-02 |
| N0-vs-N2 |
4.138800E-01 |
| N1-vs-N2 |
6.806800E-01 |
|
|
